drugset / Trial / NCT07093580
Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to investigate the safety, tolerability, and pharmacokinetics (PK) of single- and multiple-dose administration of S-892216-LAI in healthy adults.
Timeline
- Start
- 2025-07-29
- Primary completion
- 2027-05-26
- Completion
- 2027-05-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | S-892216 | Unknown | — | — |
Indications
No indication recorded.